ArticleBMC cancer2024

AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma.

Michael J Bickerdike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.